|
|
| Data-Driven Strategies To De-Risk OSD Development | Webinar | Thermo Fisher Scientific | Watch as Quentin Horgan, Director of Drugs Intelligence at GlobalData discusses how early-stage insights can improve development outcomes and reduce downstream risk. |
|
|
|
| From Molecule To Milestone: Fast Track Formulation | Webinar | AustinPx | Fast‑track, data‑driven formulation strategies align early decisions with long‑term goals, enabling First‑in‑Human progress while reducing risk, avoiding rework, and supporting development. |
|
|
|
|
By Louis Garguilo, chief editor, Outsourced Pharma | An AI-driven CDMO search tool is returning insights into how today’s sponsors select external supply-chain partners. Aptly dubbed CDMO Signal, the application aggregates FDA inspection data, clinical trial records, SEC filings, and various other attributes across over 150 CDMOs. We've noticed at least three intriguing search threads originating from this newly created search tool. | |
|
|
Is Your AI Model Trustworthy And Credible In GMP Processes? | A conversation between Gillian Buckley, Ph.D., of PhRMA and Life Science Connect's Jon O'Connell | Credibility and trustworthiness in AI models are related but distinct attributes. If you're using them in GMP manufacturing, you should understand the difference. |
|
|
INDUSTRY INSIGHTS CONTINUED |
|
|
|
| Reducing Wastewater Incineration And Carbon Emissions | Article | By Dr. Niklaus Künzle and Dr. Andreas Sieber, Lonza | To reduce CO2 emissions and recycle higher volumes of solvent, drug manufacturers must engineer specialized approaches with technologies that can be adapted to accommodate different products. |
|
|
|
|
|
|
|
OUTSOURCED PHARMA CAPABILITIES UPDATE |
|
|
|
CDMOs in biologics, cell and gene, and small molecule share their capabilities and available capabilities. See for yourself why this virtual event has become a wildly popular resource to identify options for your development and manufacturing needs. |
|
|
| Connect With Outsourced Pharma: |
|
|
|
